Prot #JBT101-DM-002: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

Project: Research project

Project Details

StatusActive
Effective start/end date1/22/19 → 2/22/23

Funding

  • Corbus Pharmaceuticals, Inc. (Prot #JBT101-DM-002)
View all
View less